142 related articles for article (PubMed ID: 30681285)
1. Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug-Drug Interactions? Preclinical and Clinical Studies With 13-cis-Retinoic Acid.
Stevison F; Kosaka M; Kenny JR; Wong S; Hogarth C; Amory JK; Isoherranen N
Clin Transl Sci; 2019 Jul; 12(4):350-360. PubMed ID: 30681285
[TBL] [Abstract][Full Text] [Related]
2. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.
Yadav AS; Stevison F; Kosaka M; Wong S; Kenny JR; Amory JK; Isoherranen N
Drug Metab Dispos; 2022 Jul; 50(7):1042-1052. PubMed ID: 35545255
[TBL] [Abstract][Full Text] [Related]
3. Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acne.
Zhao Y; Vary JC; Yadav AS; Czuba LC; Shum S; LaFrance J; Huang W; Isoherranen N; Hebert MF
Br J Clin Pharmacol; 2024 Mar; 90(3):759-768. PubMed ID: 37864393
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo.
Armstrong JL; Taylor GA; Thomas HD; Boddy AV; Redfern CP; Veal GJ
Br J Cancer; 2007 Jun; 96(11):1675-83. PubMed ID: 17486130
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy.
Topletz AR; Le HN; Lee N; Chapman JD; Kelly EJ; Wang J; Isoherranen N
Drug Metab Dispos; 2013 Feb; 41(2):312-9. PubMed ID: 23150428
[TBL] [Abstract][Full Text] [Related]
7. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
8. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats.
Yamasaki I; Yamada M; Uotsu N; Teramoto S; Takayanagi R; Yamada Y
Biomed Res; 2012; 33(4):235-42. PubMed ID: 22975634
[TBL] [Abstract][Full Text] [Related]
10. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes.
Kudo T; Endo Y; Taguchi R; Yatsu M; Ito K
Xenobiotica; 2015 May; 45(5):413-9. PubMed ID: 25470432
[TBL] [Abstract][Full Text] [Related]
11. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
Brown HS; Galetin A; Hallifax D; Houston JB
Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
[TBL] [Abstract][Full Text] [Related]
12. Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin.
Huwyler J; Wright MB; Gutmann H; Drewe J
Curr Drug Metab; 2006 Feb; 7(2):119-26. PubMed ID: 16472102
[TBL] [Abstract][Full Text] [Related]
13. Potential interactions of methylphenidate and atomoxetine with dextromethorphan.
Ciccone PE; Ramabadran K; Jessen LM
J Am Pharm Assoc (2003); 2006; 46(4):472-8. PubMed ID: 16913391
[TBL] [Abstract][Full Text] [Related]
14. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
[TBL] [Abstract][Full Text] [Related]
15. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers.
Donovan JL; DeVane CL; Chavin KD; Wang JS; Gibson BB; Gefroh HA; Markowitz JS
Drug Metab Dispos; 2004 Dec; 32(12):1333-6. PubMed ID: 15328251
[TBL] [Abstract][Full Text] [Related]
16. CYP1A2 Downregulation by Obeticholic Acid: Usefulness as a Positive Control for the In Vitro Evaluation of Drug-Drug Interactions.
Ishida C; Sanoh S; Kotake Y
J Pharm Sci; 2019 Dec; 108(12):3903-3910. PubMed ID: 31472121
[TBL] [Abstract][Full Text] [Related]
17. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.
von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Schmider J; Harmatz JS; Shader RI
J Pharm Pharmacol; 1998 Sep; 50(9):997-1004. PubMed ID: 9811160
[TBL] [Abstract][Full Text] [Related]
18. Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults.
Armani S; Ting L; Sauter N; Darstein C; Tripathi AP; Wang L; Zhu B; Gu H; Chun DY; Einolf HJ; Kulkarni S
Clin Drug Investig; 2017 May; 37(5):465-472. PubMed ID: 28155129
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids.
Farooq M; Kelly EJ; Unadkat JD
Drug Metab Dispos; 2016 May; 44(5):750-7. PubMed ID: 26965986
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition.
Schadel M; Wu D; Otton SV; Kalow W; Sellers EM
J Clin Psychopharmacol; 1995 Aug; 15(4):263-9. PubMed ID: 7593709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
